NOCD
PrivateLast Round
Series C
Jan 31, 2023
Est. Valuation
$19.96M
Total Funding Raised
$84M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NOCD operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Series C round in January 2023.
NOCD is a mental health technology company that provides a telehealth platform for the treatment of obsessive-compulsive disorder through evidence-based exposure and response prevention therapy.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NOCD Comparables
Compare NOCD with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InStride Health | 78% | |
| Talkiatry | 77% | |
| Octave | 76% |
For institutional investors. Book with your work email.
NOCD Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 31, 2023 | ||||
| Series B | Sep 21, 2021 | ||||
| Series A | Oct 8, 2020 | ||||
| Series A | Oct 1, 2019 | ||||
| Seed | Feb 12, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NOCD Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series C |
| Meridian Street Capital | Series A |
| Chicago Ventures | Series A, Series B |
| Benz Capital | Series C |
| Kaiser Permanente Ventures | Series C, Series B |
| F-Prime Capital | Series C, Series B |
| 7wire Ventures | Series A, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2026
Acquired virtual trauma therapy provider Rebound Health.
- May 6, 2025
Achieved 90% commercial insurance coverage in the U.S.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueSep 2, 2026
NOCD Inc. reaches $201M in revenue in 2025.
For institutional investors. Book with your work email.
NOCD Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NOCD's valuation, stock price, and market status.
Is NOCD a public or private company?
NOCD is a private company.
What is the current stock price of NOCD?
NOCD is a private company, so its shares have no public market price. Caplight tracks NOCD's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NOCD worth (valuation)?
NOCD's valuation is estimated at $20.0M based on funding round data.
Can I buy NOCD stock?
NOCD shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NOCD's last funding round?
NOCD's most recent funding round was Series C on January 31, 2023.
Who are the main investors in NOCD?
Key investors in NOCD include Chicago Ventures, F-Prime Capital, 7wire Ventures, Cigna Ventures, Health Enterprise Partners.
Will NOCD IPO soon?
No public IPO plans have been announced for NOCD.
How can I track NOCD secondary market activity?
Caplight tracks bids, offers, and trades in NOCD's shares on secondary markets.